Welcome to MedTech Strategist Market Pathways and to ‘Pathways Picks,’ our weekly roundup of the most important global medtech regulatory, reimbursement, and policy news.
This week MedTech Strategist is launching a new publication to deliver global regulatory and reimbursement insights to the medical device industry: MedTech Strategist Market Pathways: Global Regulatory, Reimbursement, and Policy Review. The highly-anticipated publication will be the go-to source to help industry make sense of the increasingly complex web of medtech market access policies worldwide.
At the recent MedTech Conference powered by AdvaMed, held in Philadelphia, the Community Blog caught up with Jeffrey Shuren, MD, JD, Director, Center for Devices and Radiological Health (CDRH) at the FDA. We asked him what he thought about today’s medical device regulatory climate, and where he sees the industry overall headed in the next few years. Hint: Shuren’s optimistic vision for the future of the CDRH embodies the overall theme of everything we do here at the Community Blog - build a community. Our Q&A is included below.